Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testing.
Jinghua An, Maisha Huq, Erin Speiser...
https://pubmed.ncbi.nlm.nih.gov/41554333/Actively Recruiting
Led by Rutgers, The State University of New Jersey · Updated on 2025-10-28
428
Participants Needed
2
Research Sites
39 weeks
Total Duration
This research aims to improve genetic education and testing for hereditary cancer risk among Black cancer survivors. It compares a chatbot intervention called a relational agent RA to enhanced usual care EUC to see which approach better encourages genetic education engagement and testing requests. The study also looks at how these methods affect decision-making processes and psychosocial well-being, and explores ways to support family communication of positive genetic test results through a Family Sharing Portal FSP. Participants will be randomly assigned to one of two groups the RA group or the EUC group. The RA group receives a clinical letter and access to the chatbot, which offers tailored genetic education, videos, decision support, and real-time answers, with options to request genetic testing directly through the chatbot. The EUC group receives a clinical letter recommending genetic testing and counseling, with access to clinic websites and support for testing requests. Both groups will have genetic testing results shared with them and their oncologists, with follow-up care tailored accordingly. During the study, participants will complete surveys at baseline, 1 month, and 6 months to assess engagement with genetic education, uptake of genetic testing, decision quality, and psychosocial outcomes. Researchers will monitor how participants use the interventions and their experiences. The study includes adults aged 18 to 80 who self-identify as Black or African American cancer survivors meeting specific criteria. Participation involves online access and comfort with digital tools. The study will last through August 2027, with ongoing data collection and analysis.
CONDITIONS
Addressing Genomic Disparities in Cancer Survivors
E
Erin Speiser, PhD, MA
J
Julie Chapman Greene, PhD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rutgers, The State University of New Jersey
Lead Sponsor
Georgetown University
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Relational Agent (RA) / Chatbot | Enhanced Usual Care (EUC) |
|---|---|---|
| What it is | A behavioral intervention using a relational agent (chatbot) to deliver clinical information, support genetic education, and encourage hereditary cancer genetic testing. | Written clinical letter and recommendation for genetic testing as enhanced usual care. |
| Role in the trial | Experimental arm, testing whether chatbot-driven education and engagement improves uptake of genetic testing compared with EUC. | Active comparator arm, representing improved usual care as the control reference. |
| Primary use | To increase knowledge, engagement, and actual uptake of hereditary cancer genetic testing in eligible Black cancer survivors. | To provide information and recommendation for hereditary cancer genetic testing, supporting standard engagement and access. |
| How it is given or performed | Participants receive a clinical letter plus interactive genetic education and decision support delivered through a chatbot accessed online using their device. | Participants are sent a written clinical letter plus a recommendation for genetic testing. |
| Evidence status | Efficacy and impact on genetic testing uptake are under prospective evaluation in this randomized trial; results are not yet published. | The impact of enhanced usual care in this study population is being established through trial comparison; published literature supports written recommendation as standard practice for increasing genetic testing uptake. |
| Important limitations | Trial results are not yet posted, so effectiveness and patient acceptability remain to be clarified. The intervention requires internet access and comfort with digital tools, which may limit accessibility for some patients. | Written recommendations alone, while standard, may have lower engagement and uptake than more interactive approaches. This method also depends on literacy and patient access to reliable contact information. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 6 months
Participants receive either the Relational Agent (RA) intervention, which includes engagement with genetic education, decision support, and access to genetic testing, or Enhanced Usual Care (EUC) involving a clinical letter and recommendation for genetic testing. Participants may interact with the RA or follow usual care pathways to consider genetic testing.
Surveys at baseline, 1 month, and 6 months; genetic testing if requested
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jinghua An, Maisha Huq, Erin Speiser...
https://pubmed.ncbi.nlm.nih.gov/41554333/Rutgers, The State University of New Jersey
Lead Sponsor
Georgetown University
Collaborating Sponsor